Provides marketing strategy development, FIM and IDE clinical trial organization/execution, domestic and international commercial launch planning, professional clinical education/field team development and KOL liaison for start up medical device entities in the heart failure and structural heart field

Responsible for market development and worldwide commercial launch activities for hybrid interventional heart failure therapy targeted at the structural heart market. Achievements include:- Site recruitment and execution of European FIM trial resulting in CE mark- Obtained NUB reimbursement in Germany- Established strategic account adoption in NL, DE, IT, BE, UK, CZ, PO, FR- Conceived brand identify and built recognition of Revivent product and LIVE (Less Invasive Ventricular Enhancement) procedure- Developed study nomenclature for ALIVE (domestic) and REVIVE-HF (European) clinical trials- Drove publication and podium presence with KOLs leading to impactful presentations at ACC, EuroPCR, EACTS, STS, AATS, Devices for Heart Failure, EuroHFA and HFSA. Seminal manuscripts written and accepted for JACC and Euro Journal of HF.-Established influential panel of thought leaders in surgery, cardiology and heart failure to guide company via Medical Advisory Boards- Utilized technical/clinical background to revamp procedure resulting in simplified and more effective clinical application- Developed physician training program with combination didactic and animal lab components- Developed and led Investigator Meetings for KOLs and research coordinators- Recruited, trained and managed highly effective field teams in both EU and USA- Relocated to EU to oversee launch of Revivent product resulting in $2M first year sales

Created and executed new hire sales training programs and associated physician education courses for novel AAA device

• Recruited and trained 15 key opinion leaders in minimally invasive cardiac surgery for first in man clinical trials. Managed clinical research personnel to execute 4 studies in 3 years. Company raised $35M using this data.• Developed protocols for expedited approval and executed rapid clinical trial enrollment within key accounts competing against entrenched products. This activity led to $20M licensing agreement with large competitor. • Analyzed existing market, physician needs and competition to develop critical design criteria, new branding identity & marketing strategy for international product launch• Prepared multiple abstracts/articles for presentation at medical meetings and publication in medical journals

• Built initial sales forecast and executed domestic launch plan concurrent with PMA approval of implantable female sterilization device. First year post approval sales reached $2M• Trained and managed 13 sales reps, created territory alignment to target strategic accounts & focus on high volume centers• Implemented reimbursement strategy for new sterilization procedure ultimately resulting in multiple payor approvals and dedicated CPT code. • Launched product in key international markets, initiated clinical trials, and secured first sales orders throughout Europe, Asia, and Canada. • Relocated to UK for 2001 to establish European presence & initiate hiring of local distributors

Western Regional Sales Director • Directed a staff of 9 sales representatives generating a total of $5.1 M annually in endoscopic products• Coordinated sales activities to maximize value of contractual relationships w/key GPO’s (Tenet, Kaiser, VHA) National Sales Training Manager • Designed, planned and conducted sales training program for both distributors and direct domestic sales force. • Managed the activities of Asian and European distributor networks.Marketing Manager – September 1991 to March 1995• Performed global forecasting, developed marketing strategies, created sales tools and implemented worldwide market launch of microlaparoscopy product line. These activities raised awareness of company resulting in $52M IPO• Relocated to Italy to identify, train & manage European distributors

Project lead and design engineer launching 3 major products in two years - blood cardioplegia, cardiotomy reservoir and myocardial cooling jacket

Oversaw development and manufacture of products for pressure monitoring, cardiac surgery and novel catheter interventions